IL17A and rheumatoid arthritis: Combined with previous reports, TNF, IL-17, and TLR signaling pathways are currently key pathways involved in the clinical treatment of RA.[5,53,54] Importantly, these 3 pathways are included in the predicted results of this study, and so, we believe that other pathways predicted here have important reference value.